The Creation of Knowledge

Henry Samueli, former UCLA faculty member and co-founder of Broadcom Corporation, discusses the critical role of research universities in R&D and how this impacts private industry. <more>

A Stroke of Genius

A new device developed by a California company, based on technology invented and licensed from UCLA, dramatically increases the chances of reversing the symptoms in ischemic stroke patients.<more>

Eradicating TB

UCLA researchers developed a new tuberculosis vaccine technology, licensed by Aeras, a nonprofit organization dedicated to developing new TB vaccines and distributing them to areas of the developing world where the disease is still a burden.<more>

Plant Genomics

Ceres, Inc., started by UCLA Professor Robert Goldburg in 1997, is using new technology to re-create agricultural crops that are more resistant to insects, need less fertilizer and water, and show greater tolerance to weather conditions. <more>

New inventions and advances in technology are absolute necessities for a healthy global economy. As one of the world’s leading research universities — ranked number two in the U.S. for academic research and development spending — UCLA is uniquely situated to make the most of California’s innovative drive. Through technology transfer, the process of developing applications for the results of scientific research, UCLA plays a vital role in bringing new innovation into the marketplace. In fact, new startups based on UCLA discoveries are launched every year.

UCLA also builds critical relationships with private industry to accelerate the development of UCLA discoveries. UCLA Office of Intellectual Property (OIP) creates partnerships among researchers, investors and industry, serving as a conduit between the faculty and the business community, both locally and around the world. By providing guidance to faculty and university researchers and building relationships with investors and industry leaders, OIP is rapidly moving faculty inventions and helping to fuel advances in many fields, including biomedicine and computer modeling. Since 1990, UCLA’s portfolio includes more than 1,100 inventions and 2,569 faculty inventors.

• UCLA inventors earned $6.3 million from their successful technologies for FY06.
• In FY06, UCLA received more than $918 million in research grants and contracts.

Heart Saver

Promising new cardiovascular drug D-4F has gained the attention of the pharmaceutical industry because of Bruin Pharma, a startup founded by Department of Medicine chair Alan Fogelman. <more>

Spit Test

Researchers at UCLA’s School of Dentistry discovered that by analyzing saliva, they can diagnose oral cancer with 80 percent accuracy — before the cancer even develops! <more>